These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD, McIntosh SF, Halstead AC. Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [Abstract] [Full Text] [Related]
3. Triploidy identified through second-trimester serum screening. Huang T, Alberman E, Wald N, Summers AM. Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661 [Abstract] [Full Text] [Related]
4. Cell-free fetal DNA levels in pregnancies conceived by IVF. Pan PD, Peter I, Lambert-Messerlian GM, Canick JA, Bianchi DW, Johnson KL. Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472 [Abstract] [Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA. Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [Abstract] [Full Text] [Related]
6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [Abstract] [Full Text] [Related]
7. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Muller F, Dreux S, Lemeur A, Sault C, Desgrès J, Bernard MA, Giorgetti C, Lemay C, Mirallié S, Beauchet A, French Collaborative Group. Prenat Diagn; 2003 Dec 30; 23(13):1073-6. PubMed ID: 14691995 [Abstract] [Full Text] [Related]
8. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Räty R, Virtanen A, Koskinen P, Laitinen P, Forsström J, Salonen R, Mörsky P, Ekblad U. Prenat Diagn; 2000 Mar 30; 20(3):221-3. PubMed ID: 10719325 [Abstract] [Full Text] [Related]
9. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA. Am J Obstet Gynecol; 2000 Nov 30; 183(5):1114-8. PubMed ID: 11084551 [Abstract] [Full Text] [Related]
10. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. Prenat Diagn; 1996 Jan 30; 16(1):35-8. PubMed ID: 8821850 [Abstract] [Full Text] [Related]
11. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A. Lijec Vjesn; 2003 Jan 30; 125(3-4):55-60. PubMed ID: 12899094 [Abstract] [Full Text] [Related]
13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA, Spencer K, Abushoufa RA. Prenat Diagn; 2003 Jan 30; 23(1):1-5. PubMed ID: 12533803 [Abstract] [Full Text] [Related]
14. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome. Wenstrom KD, Owen J, Boots L. Obstet Gynecol; 1997 Mar 30; 89(3):359-63. PubMed ID: 9052585 [Abstract] [Full Text] [Related]
15. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Lambert-Messerlian G, Dugoff L, Vidaver J, Canick JA, Malone FD, Ball RH, Comstock CH, Nyberg DA, Saade G, Eddleman K, Klugman S, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Prenat Diagn; 2006 Aug 30; 26(8):672-8. PubMed ID: 16764012 [Abstract] [Full Text] [Related]
16. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Maymon R, Shulman A. Prenat Diagn; 2004 Feb 30; 24(2):125-9. PubMed ID: 14974121 [Abstract] [Full Text] [Related]
17. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. Prenat Diagn; 1999 Nov 30; 19(11):1007-11. PubMed ID: 10589049 [Abstract] [Full Text] [Related]
18. Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects. Watt HC, Wald NJ. Prenat Diagn; 1998 Aug 30; 18(8):842-5. PubMed ID: 9742575 [Abstract] [Full Text] [Related]
19. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR, Lopes AM, Benn PA, Lerer T, Steinfeld JD, Ingardia CJ. J Matern Fetal Med; 2000 Aug 30; 9(3):161-4. PubMed ID: 10914623 [Abstract] [Full Text] [Related]